Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
Source link
- Turkey Seals LNG Deal With France’s TotalEnergies
- Neuralink’s ‘breakthrough device’ clearance from FDA does not mean it has cured blindness | TechCrunch
